James Gordon Liddy insider trades

Open-market stock purchases and sales by James Gordon Liddy, Director at Hepion Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 3, 2025.

Recent trades

DateStockTradeValue
Aug 19, 2026HEPA Hepion Pharmaceuticals, IncBought (not open market)—
Nov 3, 2025THAR Tharimmune, IncBought (not open market)—

Companies traded

  • HEPA Hepion Pharmaceuticals, Inc: other filings, last Aug 19, 2026
  • THAR Tharimmune, Inc: other filings, last Nov 3, 2025

Get free alerts when James Gordon Liddy files a new trade →